Department of Bioengineering, University of Pennsylvania, Philadelphia, Pennsylvania, United States of America.
PLoS One. 2012;7(3):e33174. doi: 10.1371/journal.pone.0033174. Epub 2012 Mar 14.
Pandemic and seasonal respiratory viruses are a major global health concern. Given the genetic diversity of respiratory viruses and the emergence of drug resistant strains, the targeted disruption of human host-virus interactions is a potential therapeutic strategy for treating multi-viral infections. The availability of large-scale genomic datasets focused on host-pathogen interactions can be used to discover novel drug targets as well as potential opportunities for drug repositioning.
METHODS/RESULTS: In this study, we performed a large-scale analysis of microarray datasets involving host response to infections by influenza A virus, respiratory syncytial virus, rhinovirus, SARS-coronavirus, metapneumonia virus, coxsackievirus and cytomegalovirus. Common genes and pathways were found through a rigorous, iterative analysis pipeline where relevant host mRNA expression datasets were identified, analyzed for quality and gene differential expression, then mapped to pathways for enrichment analysis. Possible repurposed drugs targets were found through database and literature searches. A total of 67 common biological pathways were identified among the seven different respiratory viruses analyzed, representing fifteen laboratories, nine different cell types, and seven different array platforms. A large overlap in the general immune response was observed among the top twenty of these 67 pathways, adding validation to our analysis strategy. Of the top five pathways, we found 53 differentially expressed genes affected by at least five of the seven viruses. We suggest five new therapeutic indications for existing small molecules or biological agents targeting proteins encoded by the genes F3, IL1B, TNF, CASP1 and MMP9. Pathway enrichment analysis also identified a potential novel host response, the Parkin-Ubiquitin Proteasomal System (Parkin-UPS) pathway, which is known to be involved in the progression of neurodegenerative Parkinson's disease.
Our study suggests that multiple and diverse respiratory viruses invoke several common host response pathways. Further analysis of these pathways suggests potential opportunities for therapeutic intervention.
大流行和季节性呼吸道病毒是全球主要的健康关注点。鉴于呼吸道病毒的遗传多样性和耐药株的出现,靶向破坏宿主-病毒相互作用是治疗多种病毒感染的潜在治疗策略。大规模的基因组数据集可用于发现新的药物靶点以及药物重新定位的潜在机会,这些数据集集中在宿主-病原体相互作用上。
方法/结果:在这项研究中,我们对涉及流感 A 病毒、呼吸道合胞病毒、鼻病毒、SARS 冠状病毒、肺炎支原体病毒、柯萨奇病毒和巨细胞病毒感染的宿主反应的微阵列数据集进行了大规模分析。通过严格的迭代分析管道发现了常见基因和途径,该管道确定了相关宿主 mRNA 表达数据集,对其进行了质量和基因差异表达分析,然后映射到途径进行富集分析。通过数据库和文献搜索找到了可能被重新利用的药物靶点。在分析的七种不同呼吸道病毒中,共鉴定出 67 个常见生物学途径,代表了十五个实验室、九种不同细胞类型和七种不同的微阵列平台。在这 67 个途径中的前二十个中观察到一般免疫反应的大量重叠,为我们的分析策略提供了验证。在这五个途径中,我们发现有 53 个差异表达基因受到至少五种病毒的影响。我们针对编码 F3、IL1B、TNF、CASP1 和 MMP9 基因的现有小分子或生物制剂提出了五个新的治疗指征。通路富集分析还鉴定了一个潜在的新的宿主反应,即 Parkin-Ubiquitin 蛋白酶体系统(Parkin-UPS)途径,该途径已知与神经退行性帕金森病的进展有关。
我们的研究表明,多种不同的呼吸道病毒会引发几种常见的宿主反应途径。对这些途径的进一步分析表明了治疗干预的潜在机会。